AzTrials
AzTrials

DepressionCITADALNCT02186730

Computerised Intervention/Treatment for Adolescent Depression and Low Mood:

A study testing Stressbusters and Websites in people with Depression, run by Leeds and York Partnership NHS Foundation Trust at 1 site in United Kingdom.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study forms the second phase of previous work to examine the effectiveness of computerised Cognitive Behaviour Therapy (cCBT) to treat adolescents with low mood/depression. Depression affects around 2% of adolescents. Read more about this study

Who is it for?
Ages 12 to 18 years
Conditions the study is for
Depression
What is being tested?
Stressbusters and Websites
Could I receive a placebo?
No, everyone receives an active treatment
How many people
48 participants
Where
1 siteUnited Kingdom
Study dates
3 Apr 2014to 1 Aug 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 12 to 18 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • 12 to 18 years
  • Low mood/depression
  • co-morbid physical illness or co-morbid non-psychotic functional disorders, such as anxiety

Who cannot join

  • Suicidality
  • Postnatally depressed
  • Suffering psychotic symptoms

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site
  • Limetrees Child Adolescent and Family Unit

    York, North Yorkshire, YO30 5RE

Other trials in United Kingdom

About this study

Official title: Computerised Intervention/Treatment for Adolescent Depression and Low Mood: Feasibility Phase 2

This study forms the second phase of previous work to examine the effectiveness of computerised Cognitive Behaviour Therapy (cCBT) to treat adolescents with low mood/depression.

Depression affects around 2% of adolescents. Antidepressants are not recommended for this age range as a first line treatment because of concerns about their usefulness and side effects. Government guidelines have supported using Cognitive Behaviour Therapy (CBT), which is effective and one of the main treatments recommended for depression. It has been suggested that computerised versions of CBT (cCBT) may be effective for treating depression in young people who may prefer this to seeing a therapist face-to-face, but little research exists to date to support this. This study examines the feasibility of running a large scale randomised controlled trial (RCT) to compare a promising cCBT program (Stressbusters) with self-help websites for adolescents with low mood and depression (LMD).

Read more

Eligible and consenting participants will complete several questionnaires to assess their mood before being randomly assigned to either cCBT (Stressbusters) or equivalent access to selected websites providing self help for LMD. Participants will complete further mood questionnaires 4 and 12 months after treatment completion/withdrawal. We have already recruited 97 individuals to this trial but aim to recruit a further 48 participants to collect further information.

We are also keen to find out whether sending participants text messages before sessions and around follow up periods will increase attendance/completion. Therefore all trial participants will receive text messages from the research team during their participation.

Conditions
Depression
Being tested
Stressbusters, Websites
Keywords
Computerised Cognitive Behaviour Therapy, Adolescents, Depression, Low Mood
Medical subject headings
Depression, Consciousness Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • StressbustersBehavioural

    cCBT

  • WebsitesBehavioural

    Self help websites

Study groups in NCT02186730
Study groupRoleWhat they receive
StressbsutersExperimentalComputerised Cognitive Behaviour package consisting of eight 30-45 minute sessions of CBT designed for 12-18 year olds. Each Stressbusters session is an interactive presentation featuring narration synchronised with videos, animations, graphics and printouts. The programme has a narrator guiding individuals through each of the eight sessions in a linear progression. Each session builds on the knowledge gained in previous sessions and on tasks carried out at home. Sessions contain flexible "add-ons" such as written fact sheets (for example about bullying, sleep problems) which can be printed out and taken away together with home practice related handouts from the programme (for example mood diary sheets). Session topics include getting activated, relapse prevention, challenging negative thoughts and problem solving
Receives: Behavioral: Stressbusters
WebsitesActive comparatorAny individuals randomised to arm 2 of the trial will spend the equivalent time accessing currently available self help websites that provide information about low mood/depression. These four websites will be the same as those used in our initial feasibility study of which, based on our preliminary data, there is evidence for their usefulness.
Receives: Behavioral: Websites

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Changes on the Short Beck Depression Inventory from baseline to 4 and 12 months follow up

    Measured: baseline, 4 months follow up, 12 months follow up

Secondary outcomes (6)
  1. Changes on the Mood and Feelings Questionnaire from baseline to 4 and 12 months follow up

    Measured: Baseline, 4 months follow up, 12 months follow up

  2. The Short Mood and Feelings Questionnaire

    Measured: up to 8 weeks

  3. Changes on the Spence Children's Anxiety Scale from baseline to 4 and 12 months follow up

    Measured: Baseline, 4 months follow up and 12 months follow up

  4. Changes in health status measured by the EQ-5D-Y from baseline to 4 and 12 months follow up

    Measured: Baseline, 4 months follow up, 12 months follow up

  5. Changes in health status measured by the HUI2 from baseline to 4 and 12 months follow up

    Measured: Baseline, 4 months follow up and 12 months follow up

  6. The number of health services used by participants between baseline, 4 months and 12 months follow up

    Measured: Baseline, 4 months follow up, 12 months follow up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Jul 2014 (estimated)
  2. Study start3 Apr 2014
  3. Primary completion27 Apr 2015
  4. Study completion1 Aug 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
48 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02186730
Sponsor's protocol ID
CITADAL
Acronym
CITADAL
Status last verified
Feb 2020
First submitted
25 Jun 2014
Last updated
21 Feb 2020
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A study testing Stressbusters and Websites in people with Depression, run by Leeds and York Partnership NHS Foundation Trust at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 21 Feb 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Changes on the Short Beck Depression Inventory from baseline to 4 and 12 months follow up (time frame: baseline, 4 months follow up, 12 months follow up). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Feb 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in